Bora has announced the appointment of Sam Ricchezza as President of North American operations. Ricchezza is the former president for WellSpring Pharma Services and has held several senior roles at a variety of contract service companies such as Patheon and AAIPharma (Alcami).
Ricchezza joins the company to advance its North American growth strategy and will be responsible for Bora’s acquisition plans locally.
“We are delighted to have Sam as part of our growing team in the U.S. He adds invaluable experience and knowledge that will be essential to the success of our two-year expansion plans within the region,” Bobby Sheng, CEO at Bora Pharmaceuticals said. “We have an ambitious growth strategy, and I can’t think of a better fit than Sam to propel this forward for our team. “As our customers outsource more of their most challenging oral solid dose (OSD) requirements, Sam is also ideally placed to offer the on-hand senior support to help navigate these challenges.”
“I was attracted to Bora because of its ability to not only offer custom solutions for complex oral solid dose products but to also facilitate a worldwide business strategy for its customers given its expertise in multiple markets,” Ricchezza said. “Bora’s activity within North America is really exciting, and having supported the sale of WellSpring Pharma Services, I am thrilled to have the opportunity to sit on the other side of the table and advance Bora’s growth strategy in the region.”